Search
Memorial Sloan Kettering Cancer Center (MSK) experts shared the results of their latest research at the 65th American Society of Hematology (ASH) Annual Meeting, held in San Diego, December 9 to 12, 2023.
Learn about 14 students who will receive doctoral degrees from the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences at MSK.
Memorial Sloan Kettering physicians have experience and specialized expertise in caring for people with uncommon cancers.
Thetis cells, a class of immune cells first described by MSK researchers in 2022, play an essential and previously unknown role in suppressing inflammatory responses to food, a new study finds.
Along with their alluring beauty, minerals — like scientific ideas — open a window onto the history of the world, Dr. Massagué says.
Feelings of guilt are common after surviving cancer, but MSK offers many support services that can help patients feel better.
Dr. Maria Jasin, whose fundamental research on repair of damaged DNA in cells has transformed our understanding of cancers linked to inherited gene mutations, was selected as the 2025 recipient of the Pearl Meister Greengard Prize — the preeminent international award recognizing outstanding women scientists.
Meet Memorial Sloan Kettering senior vice president Cynthia McCollum, who led MSK's response to the COVID-19 pandemic.
New MSK research measures unscheduled healthcare interactions in multiple myeloma patients receiving T cell redirection therapies; investigates oral bacteria’s link to gut microbiota depletion with implications for cancer patients; and shows how a universal opt-out approach could help more cancer patients quit smoking.